Zhejiang Jolly Pharmaceutical (300181.SZ) granted 5.855 million restricted stocks at a grant price of 8.07 RMB per share.
Sali Pharmaceutical (300181.SZ) announcement, the company's restricted stock incentive plan stipulates the restricted stocks...
Zhejiang Jolly Pharmaceutical (300181.SZ) announcement, the conditions for the first grant of restricted stocks under the company's 2024 restricted stock incentive plan have been achieved. It is agreed and determined that the first grant date of this incentive plan for the company is January 10, 2025. A total of 5.855 million restricted stocks will be granted to 110 incentive recipients who meet the grant conditions, with a grant price of 8.07 yuan per share.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


